Myo-inositol moderates maternal BMI and glycemia related variations in in-vitro placental (13)C-DHA-metabolism, altering their relationships with birthweight

Transplacental docosahexaenoic-acid (DHA) supply for fetal development is regulated by placental DHA-lipid metabolism. Both maternal diabetes and obesity are linked to possible decreased fetal circulating DHA and increased placental DHA-lipids. Since myo-inositol is a promising intervention for gest...

Descripción completa

Detalles Bibliográficos
Autores principales: Watkins, Oliver C., Selvam, Preben, Pillai, Reshma Appukuttan, Cracknell-Hazra, Victoria K. B., Yong, Hannah E. J., Sharma, Neha, Cazenave-Gassiot, Amaury, Bendt, Anne K., Godfrey, Keith M., Lewis, Rohan M., Wenk, Markus R., Chan, Shiao-Yng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437079/
https://www.ncbi.nlm.nih.gov/pubmed/36050341
http://dx.doi.org/10.1038/s41598-022-18309-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437079/
https://www.ncbi.nlm.nih.gov/pubmed/36050341
http://dx.doi.org/10.1038/s41598-022-18309-2

Ejemplares similares